One thing that didn't get asked on the call today was regarding the TSAT study. There was plenty discussion around what it was and when it is supposed to be published but there was nothing (that I heard) that outlined what a positive result meant. Would it allow prescribing for low energy and libido? or would it be the start of a new FDA approval process? or would it just be an FYI?
It also would've been nice to have heard about the other 2 products that are already in the US market. The estradiol spray and the dog pain killers. If the US market isn't making money why should we care about Euro and South African approvals?
FDA Drug Safety Communication, page-28
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $13.66M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.6¢ | $15.47K | 324.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 154451 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 120000 | 1 |
View Market Depth
| Last trade - 15.17pm 11/11/2024 (20 minute delay) ? |
| ACR (ASX) Chart |